Kyverna Therapeutics, Inc. (KYTX)

Market Closed

17 Jul, 20:00

NASDAQ (NGS)

7. 45

+0.01

+0.1344%

Pre Market

7. 60

+0.15 +2.0134%

347.71M Market Cap

- P/E Ratio

- Div Yield

874,266 Volume

- Eps

$ 7.44

Previous Close

Investors:

Day Range

7.2 7.68

Year Range

2.8 13.67

Want to track KYTX and more in your Portfolio? 🎯

Kyverna Therapeutics, Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
JW Jamie Wilson CAPITAL ADVISORS Inc./OK	10,000	$60,000	$74,500	$14,500	24.17%
ADD Andrew D. Dickinson GILEAD SCIENCES Inc.	4.13M	$15.43M	$30.74M	$15.31M	99.2%
Point72 Asset Management LP Point72 Asset Management LP	222,929	$1.78M	$1.66M	-$115,813.88	-6.52%
Adam Sappern Mbb Public Markets I LLC	614,477	$4.08M	$4.58M	$502,462.61	12.33%
RO Regan O'Neill Burkehill Global Management LP	200,000	$1.88M	$1.49M	-$390,000	-20.74%
Li Peng China Universal Asset Management Co. Ltd.	10,138	$52,576.94	$75,528.1	$22,951.16	43.65%
DP Drew Phillips Fortitude Family Office LLC	126	$1,087	$938.7	-$148.3	-13.64%
HFT Hui Fai Tam Caitong International Asset Management Co. Ltd.	2,124	$18,330	$15,823.8	-$2,506.2	-13.67%
Jim Harding Propel Bio Management LLC	644,421	$6.06M	$4.8M	-$1.26M	-20.74%
Bryan Buchert Kera Capital Partners Inc.	108,083	$373,486.46	$805,218.35	$431,731.89	115.6%
PLC Peapod Lane Capital LLC Peapod Lane Capital LLC	40,404	$78,597.69	$301,009.8	$222,412.11	282.98%
FDW Fourth Dimension Wealth LLC Fourth Dimension Wealth LLC	250	$935	$1,862.5	$927.5	99.2%
GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.	977	$3,928.98	$7,278.65	$3,349.67	85.26%